Last Updated: November 8, 2026

NICORETTE (MINT) Drug Patent Profile

Name: NICORETTE (MINT) Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Nicorette (mint), and when can generic versions of Nicorette (mint) launch?

Nicorette (mint) is a drug marketed by Haleon Us Holdings and is included in two NDAs.

The generic ingredient in NICORETTE (MINT) is nicotine polacrilex. There is one drug master file entry for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nicorette (mint)

A generic version of NICORETTE (MINT) was approved as nicotine polacrilex by P AND L on March 15^th, 1999.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NICORETTE (MINT)?
What are the global sales for NICORETTE (MINT)?
What is Average Wholesale Price for NICORETTE (MINT)?

Summary for NICORETTE (MINT)

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	2
Clinical Trials:	42
DailyMed Link:	NICORETTE (MINT) at DailyMed

Drug patent expirations by year for NICORETTE (MINT)

Recent Clinical Trials for NICORETTE (MINT)

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NYU Langone Health	Phase 1
Washington State University	Early Phase 1
Office of Dietary Supplements (ODS)	Early Phase 1

See all NICORETTE (MINT) clinical trials

Pharmacology for NICORETTE (MINT)

Drug Class	Cholinergic Nicotinic Agonist

US Patents and Regulatory Information for NICORETTE (MINT)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Haleon Us Holdings	NICORETTE (MINT)	nicotine polacrilex	GUM, CHEWING;BUCCAL	018612-003	Dec 23, 1998		OTC	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Haleon Us Holdings	NICORETTE (MINT)	nicotine polacrilex	GUM, CHEWING;BUCCAL	020066-003	Dec 23, 1998		OTC	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for NICORETTE (MINT)

See the table below for patents covering NICORETTE (MINT) around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Argentina	053731	AROMATIZACION DE GOMAS DE MASCAR QUE CONTIENEN FARMACOS	⤷ Start Trial
Australia	2006247847	Flavoring of drug-containing chewing gums	⤷ Start Trial
Brazil	PI0611520	aromatização de gomas de mascar contendo drogas	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.